Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma

ABSTRACT Merkel cell polyomavirus is the primary etiological agent of the aggressive skin cancer Merkel cell carcinoma (MCC). Recent studies have revealed that UV radiation is the primary mechanism for somatic mutagenesis in nonviral forms of MCC. Here, we analyze the whole transcriptomes and genomes of primary MCC tumors. Our study reveals that virus-associated tumors have minimally altered genomes compared to non-virus-associated tumors, which are dominated by UV-mediated mutations. Although virus-associated tumors contain relatively small mutation burdens, they exhibit a distinct mutation signature with observable transcriptionally biased kataegic events. In addition, viral integration sites overlap focal genome amplifications in virus-associated tumors, suggesting a potential mechanism for these events. Collectively, our studies indicate that Merkel cell polyomavirus is capable of hijacking cellular processes and driving tumorigenesis to the same severity as tens of thousands of somatic genome alterations. IMPORTANCE A variety of mutagenic processes that shape the evolution of tumors are critical determinants of disease outcome. Here, we sequenced the entire genome of virus-positive and virus-negative primary Merkel cell carcinomas (MCCs), revealing distinct mutation spectra and corresponding expression profiles. Our studies highlight the strong effect that Merkel cell polyomavirus has on the divergent development of viral MCC compared to the somatic alterations that typically drive nonviral tumorigenesis. A more comprehensive understanding of the distinct mutagenic processes operative in viral and nonviral MCCs has implications for the effective treatment of these tumors. A variety of mutagenic processes that shape the evolution of tumors are critical determinants of disease outcome. Here, we sequenced the entire genome of virus-positive and virus-negative primary Merkel cell carcinomas (MCCs), revealing distinct mutation spectra and corresponding expression profiles. Our studies highlight the strong effect that Merkel cell polyomavirus has on the divergent development of viral MCC compared to the somatic alterations that typically drive nonviral tumorigenesis. A more comprehensive understanding of the distinct mutagenic processes operative in viral and nonviral MCCs has implications for the effective treatment of these tumors.

[1]  W. Haseltine,et al.  UV-induced mutation hotspots occur at DNA damage hotspots , 1982, Nature.

[2]  S. Rabkin,et al.  The role of DNA polymerase in base substitution mutagenesis on non-instructional templates. , 1982, Biochimie.

[3]  L. Mullenders,et al.  UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. , 2001, Journal of photochemistry and photobiology. B, Biology.

[4]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[5]  L. Clegg,et al.  Epidemiology of primary Merkel cell carcinoma in the United States. , 2003, Journal of the American Academy of Dermatology.

[6]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[7]  P. Boukamp Non-melanoma skin cancer: what drives tumor development and progression? , 2005, Carcinogenesis.

[8]  E. Birney,et al.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs. , 2008, Genome research.

[9]  Yuan Chang,et al.  T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus , 2008, Proceedings of the National Academy of Sciences.

[10]  M. Werner,et al.  Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. , 2008, Cancer research.

[11]  J. Reichrath,et al.  UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. , 2008, Advances in experimental medicine and biology.

[12]  H. Schuller,et al.  GABAB receptor is a novel drug target for pancreatic cancer , 2008, Cancer.

[13]  Arash Mostaghimi,et al.  Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. , 2008, Journal of the American Academy of Dermatology.

[14]  B. Thiers,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2009 .

[15]  Ning Ma,et al.  BLAST+: architecture and applications , 2009, BMC Bioinformatics.

[16]  C. Buck,et al.  Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. , 2010, Cell host & microbe.

[17]  Robert B. Hartlage,et al.  This PDF file includes: Materials and Methods , 2009 .

[18]  Long-Bang Chen,et al.  GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  Yuan Chang,et al.  Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens , 2010, Journal of Virology.

[20]  M. Flaig,et al.  Prevalence of MCPyV in Merkel cell carcinoma and non‐MCC tumors , 2010, Journal of cutaneous pathology.

[21]  A. Dempsey,et al.  The role of HPV in head and neck cancer and review of the HPV vaccine. , 2011, Preventive medicine.

[22]  Adam D. Wier,et al.  Raw Sewage Harbors Diverse Viral Populations , 2011, mBio.

[23]  J. Miller,et al.  Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.

[24]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[25]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[26]  Yongwook Choi,et al.  A fast computation of pairwise sequence alignment scores between a protein and a set of single-locus variants of another protein , 2012, BCB.

[27]  Thomas D. Wu,et al.  The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. , 2012, Genome research.

[28]  Angela M. Liu,et al.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma , 2012, Nature Genetics.

[29]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[30]  T. Petrella,et al.  Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. , 2012, Virology.

[31]  Steven A. Roberts,et al.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.

[32]  Xin Wang,et al.  Merkel Cell Polyomavirus Large T Antigen Disrupts Host Genomic Integrity and Inhibits Cellular Proliferation , 2013, Journal of Virology.

[33]  James T. Elder,et al.  Distinct gene expression profiles of viral- and non-viral associated Merkel cell carcinoma revealed by transcriptome analysis , 2012, The Journal of investigative dermatology.

[34]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[35]  N. A. Temiz,et al.  Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.

[36]  M. Stratton,et al.  Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.

[37]  M. Ronaghi,et al.  Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. , 2013, Carcinogenesis.

[38]  Serena Nik-Zainal,et al.  Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.

[39]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[40]  S. Mori,et al.  In Vivo and In Vitro Studies Suggest a Possible Involvement of HPV Infection in the Early Stage of Breast Carcinogenesis via APOBEC3B Induction , 2014, PloS one.

[41]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[42]  S. Henderson,et al.  APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. , 2014, Cell reports.

[43]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[44]  Shyam S Jayaraman,et al.  Mutational landscape of basal cell carcinomas by whole-exome sequencing. , 2014, The Journal of investigative dermatology.

[45]  V. C. Vieira,et al.  Human Papillomavirus E6 Triggers Upregulation of the Antiviral and Cancer Genomic DNA Deaminase APOBEC3B , 2014, mBio.

[46]  Trevor J Pugh,et al.  Landscape of genomic alterations in cervical carcinomas , 2013, Nature.

[47]  James M. Pipas,et al.  SummonChimera infers integrated viral genomes with nucleotide precision from NGS data , 2014, BMC Bioinformatics.

[48]  M. Stratton,et al.  Mutational signatures: the patterns of somatic mutations hidden in cancer genomes , 2014, Current opinion in genetics & development.

[49]  L. Pardo,et al.  The roles of K+ channels in cancer , 2013, Nature Reviews Cancer.

[50]  Gisela Mir Arnau,et al.  UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas. , 2015, Cancer research.

[51]  Jessica Zucman-Rossi,et al.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets , 2015, Nature Genetics.

[52]  Nicolai J. Birkbak,et al.  Clonal status of actionable driver events and the timing of mutational processes in cancer evolution , 2015, Science Translational Medicine.

[53]  S. Dhanasekaran,et al.  The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. , 2015, Cancer research.

[54]  Yongwook Choi,et al.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..

[55]  Y. Ishii,et al.  Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6. , 2015, Biochemical and biophysical research communications.

[56]  Philip R. Cohen,et al.  Merkel Cell Carcinoma with a Suppressor of Fused ( SUFU ) Mutation : Case Report and Potential Therapeutic Implications , 2015 .

[57]  Julian Gehring,et al.  SomaticSignatures: inferring mutational signatures from single-nucleotide variants , 2014, bioRxiv.

[58]  Philip R. Cohen,et al.  Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics , 2016, Oncotarget.

[59]  P. Hanawalt,et al.  Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair , 2016, Cell.

[60]  David C. Jones,et al.  Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.

[61]  M. Jiang,et al.  Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses , 2016, Journal of Virology.